Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21661 | 353 | 36.6 | 62% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
483 | 14947 | GANGLIOSIDES//SIALYLTRANSFERASE//SIALIC ACID |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEUGCGM3 | Author keyword | 8 | 100% | 1% | 5 |
2 | N GLYCOLYL GM3 | Author keyword | 6 | 80% | 1% | 4 |
3 | CMP N ACETYLNEURAMINIC ACID HYDROXYLASE | Author keyword | 6 | 71% | 1% | 5 |
4 | APOPTOSIS INDUCING NUCLEOSIDES | Author keyword | 6 | 100% | 1% | 4 |
5 | N GLYCOLYLNEURAMINIC ACID | Author keyword | 5 | 23% | 6% | 20 |
6 | NATURAL SUPPRESSOR CELL | Author keyword | 4 | 67% | 1% | 4 |
7 | CMP NEU5AC HYDROXYLASE | Author keyword | 3 | 100% | 1% | 3 |
8 | NEUGC CONTAINING GANGLIOSIDE | Author keyword | 3 | 100% | 1% | 3 |
9 | NGCGM3 | Author keyword | 3 | 100% | 1% | 3 |
10 | NGCGM3 GANGLIOSIDE | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HANGANUTZIU DEICHER ANTIGEN | 38 | 66% | 10% | 35 |
2 | GLYCOLYLNEURAMINIC ACID | 23 | 45% | 11% | 38 |
3 | MOUSE LIVER CYTOSOL | 19 | 71% | 4% | 15 |
4 | ACID CONTAINING GANGLIOSIDES | 18 | 83% | 3% | 10 |
5 | GLYCOLOYLNEURAMINIC ACID | 18 | 83% | 3% | 10 |
6 | CONTAINING GANGLIOSIDES | 13 | 67% | 3% | 12 |
7 | GLYCOLYNEURAMINIC ACID | 11 | 78% | 2% | 7 |
8 | NEUGC CONTAINING GANGLIOSIDES | 10 | 73% | 2% | 8 |
9 | NONHUMAN SIALIC ACID | 10 | 38% | 6% | 21 |
10 | N GLYCOLYLNEURAMINIC ACID | 10 | 17% | 14% | 50 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
N-glycolylneuraminic acid in human tumours | 2001 | 131 | 83 | 64% |
Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation | 2012 | 40 | 109 | 27% |
NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines | 2010 | 25 | 51 | 61% |
N-glycolylneuraminic acid deficiency in humans | 2001 | 57 | 111 | 42% |
Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients | 2014 | 3 | 45 | 31% |
Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy | 2012 | 15 | 103 | 21% |
Genetic basis for the lack of N-glycolylneuraminic acid expression in human tissues and its implication to human evolution | 2006 | 3 | 26 | 54% |
A dietary non-human sialic acid may facilitate hemolytic-uremic syndrome | 2009 | 9 | 18 | 33% |
Altered sphingolipid metabolism induced by tumor hypoxia - New vistas in glycolipid tumor markers | 2010 | 24 | 46 | 17% |
The N-glycolyneuraminic acid, a sialic acid: Its relation with the biodiversity and immune and infection processes | 2011 | 0 | 23 | 39% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GLYCOBIOL TRAINING | 3 | 10% | 7.9% | 28 |
2 | INT EPIDEM | 1 | 100% | 0.6% | 2 |
3 | RECOGNIT BIOL ACT ASSAYS | 1 | 100% | 0.6% | 2 |
4 | TUMOR IMMUNOL DIRECT | 1 | 40% | 0.6% | 2 |
5 | MICRO IMMUNOL | 1 | 50% | 0.3% | 1 |
6 | MICROBIAL DIS PATHOL | 1 | 50% | 0.3% | 1 |
7 | PL BIOL SCI MICROBIOL HYG | 1 | 50% | 0.3% | 1 |
8 | VET MED BIOCHEM KITA KU | 1 | 50% | 0.3% | 1 |
9 | ONCOL ANGEL ROFFO | 1 | 29% | 0.6% | 2 |
10 | INNOVAT MANAGING DIRECT | 0 | 33% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000216006 | ACHATININ H//INFLUENZA C VIRUS//9 O ACETYLATED SIALOGLYCOCONJUGATES |
2 | 0.0000191325 | ANTIANGIOGENIC CANCER VACCINE//CELL PROTEOMIC FOOTPRINTING//HER1 VACCINE |
3 | 0.0000152447 | POLYVALENT ANTIGEN//AUTOLOGOUS ANTIBODY//B700 |
4 | 0.0000135355 | SIGLEC//SIGLECS//SIGLEC 8 |
5 | 0.0000135061 | GANGLIOSIDES//GANGLIOSIDE//GM1 GANGLIOSIDE |
6 | 0.0000125037 | SERUM SIALIC ACID//LIPID BOUND SIALIC ACID//TOTAL SIALIC ACID |
7 | 0.0000108943 | BELAGENPUMATUCEL L//SRL172//PA MSHA |
8 | 0.0000088055 | TUMOR VACCINOL//GLYCOPEPTIDES//CARL S MARVEL S |
9 | 0.0000078043 | N ACETYLNEURAMINATE LYASE//N ACETYLNEURAMINIC ACID//KDN |
10 | 0.0000077621 | ANTI IDIOTYPIC ANTIBODY//ANTI ANTI IDIOTYPIC ANTIBODY//INTERNAL IMAGE |